What one share of SeaStar Medical Holding holds
We are a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life. Our Selective Cytopheretic Device (“SCD”) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body.
SeaStar Medical Holding’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.48 |
|---|---|
| Profit | −$3.83 |
| Cash and investments | $1.63 |
| Debt | $0.12 |
| Book value | $1.01 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | — | −$158.73 | — | — | — | −$97.25 |
| 2022 | — | −$371.14 | — | — | — | −$408.71 |
| 2023 | $0.00 | −$302.63 | — | — | — | — |
| 2024 | $0.36 | −$66.33 | — | — | — | −$3.36 |
| 2025 | $0.60 | −$5.86 | — | — | — | $2.71 |
Common questions about SeaStar Medical Holding
How much does one share of SeaStar Medical Holding earn?
Over the last 12 months, SeaStar Medical Holding lost $3.83 for each share on $0.48 of sales.
Does SeaStar Medical Holding pay a dividend?
SeaStar Medical Holding didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is SeaStar Medical Holding’s book value per share?
SeaStar Medical Holding’s book value is $1.01 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of SeaStar Medical Holding have?
Each share of SeaStar Medical Holding has $1.63 of cash and investments and $0.12 of debt, as of June 30, 2026.
Has SeaStar Medical Holding bought back shares?
SeaStar Medical Holding’s share count rose about 7060% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.